Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Act
Sponsored by IQVIA RDS Inc.
Active
$133.3K Funding
4 People
External
Related Topics
clinical trials,
inflammatory bowel disease,
drug efficacy,
safety evaluation,
immunomodulatory therapy
People
Kirsten Anderson
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator IV
Sasha Taleban
Principal Investigator (PI)
Medicine
﹒Associate Professor
Maria Gordon
(CD)
Az Health Sciences Division
﹒Clinical Research Manager II
Gustavo Cornejo
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator III
